Differential effects of protein synthesis inhibition on CTL and targets in cell-mediated cytotoxicity

Area of Science:

• Immunology
• Cellular Biology

Background:

• Cytotoxic T lymphocyte (CTL) mediated target cell lysis is crucial for immune responses but remains poorly understood.
• The specific roles of effector (CTL) and target cells in the lytic process require further elucidation.

Purpose of the Study:

• To investigate the necessity of de novo protein synthesis in both CTL and target cells during the lytic process.
• To understand the impact of protein synthesis inhibition on CTL activation and target cell susceptibility to lysis.

Main Methods:

• Inhibition of protein synthesis in either CTL or target cells prior to cytotoxic assays.
• Assessment of CTL activation and target cell lysis.
• Evaluation of CTL-target cell interaction using MHC class I expression and competitive inhibition assays.
• Measurement of intracellular calcium (Ca2+) mobilization and inositol phosphate generation in CTL.

Main Results:

• De novo protein synthesis is not required in effector or target cells during the lytic reaction itself.
• CTL activation necessitates protein synthesis, and inhibitors cause a cycling of activity, suggesting a stimulus-secretion mechanism.
• Protein synthesis inhibition in target cells rapidly and irreversibly abolishes their susceptibility to lysis.
• Drug-treated targets maintain MHC class I expression, interact with CTL, and trigger CTL activation (Ca2+ flux, inositol phosphates), but cannot be lysed.

Conclusions:

• CTL activation is dependent on protein synthesis, while the lytic machinery itself is not.
• Target cells treated with protein synthesis inhibitors can initiate CTL responses but lack a critical component for successful lysis.
• This suggests a complex interplay where target cells must possess specific, synthesis-dependent factors to be effectively eliminated by CTL.